Kazia Therapeutics Ltd (KZIA)
CIK 1075880 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kazia Therapeutics Ltd.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 1, 2026 | 6-K | 0001213900-26-096263 |
| Sep 1, 2026 | 424B3 | 0001213900-26-096268 |
| Sep 1, 2026 | 424B3 | 0001213900-26-096265 |
| Sep 1, 2026 | 424B3 | 0001213900-26-096267 |
| Sep 1, 2026 | 424B3 | 0001213900-26-096266 |
| Aug 31, 2026 | 6-K | 0001213900-26-095310 |
| Aug 31, 2026 | 424B3 | 0001213900-26-095353 |
| Aug 31, 2026 | 424B3 | 0001213900-26-095349 |
| Aug 31, 2026 | 6-K | 0001213900-26-095348 |
| Aug 31, 2026 | 424B3 | 0001213900-26-095355 |
| Aug 31, 2026 | 424B5 | 0001213900-26-095303 |
| Aug 31, 2026 | 424B3 | 0001213900-26-095351 |
| Aug 28, 2026 | 424B5 | 0001213900-26-094600 |
| Aug 28, 2026 | 6-K | 0001213900-26-094603 |
| Aug 27, 2026 | 424B5 | 0001213900-26-094426 |
| Aug 27, 2026 | 424B3 | 0001213900-26-094413 |
| Aug 27, 2026 | 424B3 | 0001213900-26-094409 |
| Aug 27, 2026 | 6-K | 0001213900-26-094408 |
| Aug 27, 2026 | 424B3 | 0001213900-26-094421 |
| Aug 27, 2026 | 424B3 | 0001213900-26-094418 |
| Aug 19, 2026 | SCHEDULE 13G/A | 0000921895-26-002261 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001104659-26-097117 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001193125-26-352951 |
| Jul 28, 2026 | 424B3 | 0001213900-26-081983 |
| Jul 28, 2026 | 424B3 | 0001213900-26-081984 |